{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:22:48Z","timestamp":1784892168412,"version":"3.55.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.lfs.2021.120185","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T22:29:15Z","timestamp":1638311355000},"page":"120185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Pirfenidone and vitamin D mitigate renal fibrosis induced by doxorubicin in mice with Ehrlich solid tumor"],"prefix":"10.1016","volume":"288","author":[{"given":"Reem M.","family":"Hazem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar A.","family":"Antar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yossef K.","family":"Nafea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Al-Karmalawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona F.","family":"El-Azab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.120185_bb0005","article-title":"Exploratory study of breast cancer screening practices of urban women: a closer look at who is and is not getting screened","volume":"26","author":"Millon-Underwood","year":"2015","journal-title":"ABNF J."},{"key":"10.1016\/j.lfs.2021.120185_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5000054","article-title":"Renal fibrosis: new insights into the pathogenesis and therapeutics","volume":"69","author":"Liu","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2021.120185_bb0015","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1046\/j.1523-1755.2000.00342.x","article-title":"Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events","volume":"58","author":"Wang","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2021.120185_bb0020","series-title":"Doxorubicin Induced Nephrotoxicity: Protective Effect of Nicotinamide","first-page":"2011","author":"Ayla","year":"2011"},{"key":"10.1016\/j.lfs.2021.120185_bb0025","series-title":"Protective Effects of Leflunomide Against Ischemia-Reperfusion Injury of the Rat Liver","first-page":"428","volume":"vol. 22","author":"Karaman","year":"2006"},{"key":"10.1016\/j.lfs.2021.120185_bb0030","first-page":"86","article-title":"Adriamycin-induced oxidative stress is prevented by mixed hydro-alcoholic extract of Nigella sativa and Curcuma longa in rat kidney","volume":"6","author":"Mohebbati","year":"2016","journal-title":"Avicenna J. Phytomedicine"},{"key":"10.1016\/j.lfs.2021.120185_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10157-016-1268-6","article-title":"Podocyte-specific NF-\u03baB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice","volume":"21","author":"Yamashita","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.lfs.2021.120185_bb0040","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/toxsci\/kfw096","article-title":"Mechanisms of doxorubicin toxicity in pancreatic \u03b2-cells","volume":"152","author":"Heart","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.lfs.2021.120185_bb0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1755-1536-3-16","article-title":"The multifaceted role of pirfenidone and its novel targets","volume":"3","author":"Mac\u00edas-Barrag\u00e1n","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.lfs.2021.120185_bb0050","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1167\/iovs.09-4257","article-title":"Antifibrotic effect of Pirfenidone on orbital fibroblasts of patients with thyroid-associated ophthalmopathy by decreasing TIMP-1 and collagen levels","volume":"51","author":"Kim","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.lfs.2021.120185_bb0055","series-title":"Vitamin D Status and Mortality Risk in CKD: A Meta-analysis of Prospective Studies","first-page":"374","volume":"vol. 58","author":"Pilz","year":"2011"},{"key":"10.1016\/j.lfs.2021.120185_bb0060","series-title":"Chronic Kidney Disease, Hypovitaminosis D, and Mortality in the United States","first-page":"977","volume":"vol. 76","author":"Mehrotra","year":"2009"},{"key":"10.1016\/j.lfs.2021.120185_bb0065","series-title":"Association of Kidney Function, Vitamin D Deficiency, and Circulating Markers of Mineral and Bone Disorders in CKD","first-page":"544","volume":"vol. 58","author":"Ure\u00f1a-Torres","year":"2011"},{"key":"10.1016\/j.lfs.2021.120185_bb0070","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1046\/j.1523-1755.1998.00951.x","article-title":"Effect of 1, 25 (OH) 2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats","volume":"53","author":"Schwarz","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2021.120185_bb0075","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1681\/ASN.2006050520","article-title":"Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy","volume":"17","author":"Tan","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2021.120185_bb0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3390\/ph13110348","article-title":"Pirfenidone and vitamin D ameliorate cardiac fibrosis induced by doxorubicin in Ehrlich ascites carcinoma bearing mice: modulation of monocyte chemoattractant protein-1 and Jun N-terminal kinase-1 pathways","volume":"13","author":"Saleh","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.lfs.2021.120185_bb0085","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/life11080759","article-title":"VEGFR-mediated cytotoxic activity of Pulicaria undulata isolated metabolites: a biological evaluation and in silico study","volume":"11","author":"Elhady","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.lfs.2021.120185_bb0090","series-title":"Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity","first-page":"185","volume":"vol. 56","author":"Minotti","year":"2004"},{"key":"10.1016\/j.lfs.2021.120185_bb0095","series-title":"Pirfenidone Normalizes the Tumor Microenvironment to Improve Chemotherapy","first-page":"24506","volume":"vol. 8","author":"Polydorou","year":"2017"},{"key":"10.1016\/j.lfs.2021.120185_bb0100","article-title":"Vitamin D attenuates kidney fibrosis via reducing fibroblast expansion, inflammation, and epithelial cell apoptosis","volume":"62","author":"Arfian","year":"2016"},{"key":"10.1016\/j.lfs.2021.120185_bb0105","series-title":"Chemical Computing Group Inc 1010 Sherbooke St. West, Suite# 910, Montreal \u2026","author":"Inc. CCG. Molecular operating environment (MOE)","year":"2016"},{"key":"10.1016\/j.lfs.2021.120185_bb0110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fchem.2021.628398","article-title":"Revisiting activity of some nocodazole analogues as a potential anticancer drugs using molecular docking and DFT calculations","volume":"9","author":"Khattab","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.lfs.2021.120185_bb0115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.sajb.2021.02.007","article-title":"Bioassay-guided isolation of a new cytotoxic ceramide from Cyperus rotundus L","volume":"139","author":"Samra","year":"2021","journal-title":"S. Afr. J. Bot."},{"key":"10.1016\/j.lfs.2021.120185_bb0120","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1021\/jm300025r","article-title":"Discovery of checkpoint kinase inhibitor (S)-5-(3-fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by structure-based design and optimization of thiophenecarboxamide ureas","volume":"55","author":"Oza","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120185_bb0125","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nsb0197-64","article-title":"The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions","volume":"4","author":"Lubkowski","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.lfs.2021.120185_bb0130","series-title":"Molecular Docking and Dynamics Simulations Reveal the Potential of Anti-HCV Drugs to Inhibit COVID-19 Main Protease","author":"Al-Karmalawy","year":"2021"},{"key":"10.1016\/j.lfs.2021.120185_bb0135","series-title":"Molecular Docking Reveals the Potential of Cleome Amblyocarpa Isolated Compounds to Inhibit COVID-19 Virus Main Protease","first-page":"16752","volume":"vol. 44","author":"Zaki","year":"2020"},{"key":"10.1016\/j.lfs.2021.120185_bb0140","doi-asserted-by":"crossref","first-page":"13990","DOI":"10.1039\/D0NJ02844D","article-title":"Molecular modelling of mebendazole polymorphs as a potential colchicine binding site inhibitor","volume":"44","author":"Al-Karmalawy","year":"2020","journal-title":"NJoC"},{"key":"10.1016\/j.lfs.2021.120185_bb0145","article-title":"Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease","volume":"6","author":"Alnajjar","year":"2020"},{"key":"10.1016\/j.lfs.2021.120185_bb0150","series-title":"Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering With the mTOR Pathway and Inhibition of Calmodulin: In Vitro and Molecular Docking Studies","first-page":"1330","volume":"vol. 3","author":"Eliaa","year":"2020"},{"key":"10.1016\/j.lfs.2021.120185_bb0155","first-page":"845","article-title":"The performance of current methods in ligand\u2013protein docking","author":"McConkey","year":"2002","journal-title":"Curr. Sci."},{"key":"10.1016\/j.lfs.2021.120185_bb0160","article-title":"Oxidative\/nitrative stress and inflammation drive progression of doxorubicin-induced renal fibrosis in rats as revealed by comparing a normal and a fibrosis-resistant rat strain","volume":"10","author":"Szalay","year":"2015"},{"key":"10.1016\/j.lfs.2021.120185_bb0165","series-title":"Periostin Creates a Tumor-supportive Microenvironment in the Pancreas by Sustaining Fibrogenic Stellate Cell Activity","first-page":"1447","volume":"vol. 132","author":"Erkan","year":"2007"},{"key":"10.1016\/j.lfs.2021.120185_bb0170","series-title":"Periostin Expression and Epithelial-Mesenchymal Transition in Cancer: A Review and an Update","first-page":"465","volume":"vol. 459","author":"Morra","year":"2011"},{"key":"10.1016\/j.lfs.2021.120185_bb0175","series-title":"Pirfenidone Inhibits Pancreatic Cancer Desmoplasia by Regulating Stellate Cells","author":"Kozono","year":"2013"},{"key":"10.1016\/j.lfs.2021.120185_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PPO.0b013e3181c51ee6","article-title":"Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy","volume":"16","author":"Trump","year":"2010","journal-title":"Cancer J. (Sudbury, Mass)"},{"key":"10.1016\/j.lfs.2021.120185_bb0185","first-page":"249","article-title":"Cholecalciferol and cancer: is it a big D3-eal?","volume":"3","author":"Wickham","year":"2012","journal-title":"J. Adv. Pract. Oncol."},{"key":"10.1016\/j.lfs.2021.120185_bb0190","first-page":"3371","article-title":"1\u03b1, 25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells","volume":"6","author":"Swami","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2021.120185_bb0195","first-page":"235","article-title":"1, 24 (S)-Dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors","volume":"25","author":"Zinser","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2021.120185_bb0200","series-title":"Effect of Insulin Treatment on Some Metabolic Changes on Experimentally Induced Tumor in Female Mice","first-page":"61","volume":"vol. 15","author":"Hussein","year":"1997"},{"key":"10.1016\/j.lfs.2021.120185_bb0205","series-title":"Ameliorative Effect of Curcumin and Tannic Acid On Tumor-induced in Female Mice","first-page":"61","volume":"vol. 1","author":"Omayma","year":"2011"},{"key":"10.1016\/j.lfs.2021.120185_bb0210","series-title":"Evaluation of Anti-fibrotic Activity of Ethanolic Extract of Nelumbo Nuciferagaertn. Seed Against Doxorubicin and Unilateral Ureter Obstruction-induced Renal Fibrosis","first-page":"66","volume":"vol. 11","author":"Rushendran","year":"2017"},{"key":"10.1016\/j.lfs.2021.120185_bb0215","series-title":"Altered Antioxidant Defence in a Mouse Adriamycin Model of Glomerulosclerosis","first-page":"147","volume":"vol. 16","author":"Deman","year":"2001"},{"key":"10.1016\/j.lfs.2021.120185_bb0220","series-title":"Renal Tubulointerstitial Fibrosis: A Review in Animal Models","first-page":"75","volume":"vol. 2","author":"Zhao","year":"2015"},{"key":"10.1016\/j.lfs.2021.120185_bb0225","series-title":"Beyond Proteinuria: VDR Activation Reduces Renal Inflammation in Experimental Diabetic Nephropathy","volume":"vol. 302","author":"Sanchez-Ni\u00f1o","year":"2011"},{"key":"10.1016\/j.lfs.2021.120185_bb0230","series-title":"Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System","first-page":"278","volume":"vol. 2","author":"Tanios","year":"2012"},{"key":"10.1016\/j.lfs.2021.120185_bb0235","series-title":"Macrophages in Kidney Injury, Inflammation, and Fibrosis","first-page":"183","volume":"vol. 30","author":"Cao","year":"2015"},{"key":"10.1016\/j.lfs.2021.120185_bb0240","series-title":"Characterization of the Inflammatory Response During Ehrlich Ascitic Tumor Development","first-page":"83","volume":"vol. 71","author":"Fernandes","year":"2015"},{"key":"10.1016\/j.lfs.2021.120185_bb0245","series-title":"Statins Revert Doxorubicin Resistance Via Nitric Oxide in Malignant Mesothelioma","first-page":"17","volume":"vol. 119","author":"Riganti","year":"2006"},{"key":"10.1016\/j.lfs.2021.120185_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127090","article-title":"Oxidative\/nitrative stress and inflammation drive progression of doxorubicin-induced renal fibrosis in rats as revealed by comparing a normal and a fibrosis-resistant rat strain","volume":"10","author":"Szalay","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.120185_bb0255","first-page":"3319","article-title":"Schisandra chinensis lignans suppresses the production of inflammatory mediators regulated by NF-\u03baB, AP-1, and IRF3 in lipopolysaccharide-stimulated RAW264","volume":"23","author":"Luo","year":"2018","journal-title":"7 Cells"},{"key":"10.1016\/j.lfs.2021.120185_bb0260","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1159\/000356602","article-title":"Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK\/NF\u03baB pathway in H9c2 cardiac cells","volume":"32","author":"Guo","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2021.120185_bb0265","series-title":"The Nuclear Factor NF-\u03baB Pathway in Inflammation","author":"Lawrence","year":"2009"},{"key":"10.1016\/j.lfs.2021.120185_bb0270","series-title":"Renoprotective Properties of Pirfenidone in Subtotally Nephrectomized Rats","first-page":"118","volume":"vol. 629","author":"Takakuta","year":"2010"},{"key":"10.1016\/j.lfs.2021.120185_bb0275","series-title":"Pirfenidone Inhibits the Induction of iNOS Stimulated by Interleukin-1\u03b2 at a Step of NF-\u03baB DNA Binding in Hepatocytes","first-page":"730","volume":"vol. 41","author":"Nakanishi","year":"2004"},{"key":"10.1016\/j.lfs.2021.120185_bb0280","series-title":"Pirfenidone Inhibits Fibrocyte Accumulation in the Lungs in Bleomycin-induced Murine Pulmonary Fibrosis","first-page":"16","volume":"vol. 15","author":"Inomata","year":"2014"},{"key":"10.1016\/j.lfs.2021.120185_bb0285","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1523-1755.2001.059002415.x","article-title":"Transcription factor-\u03baB (NF-\u03baB) and renal disease","volume":"59","author":"Guijarro","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2021.120185_bb0290","article-title":"Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells","volume":"8","author":"Kim","year":"2013"},{"key":"10.1016\/j.lfs.2021.120185_bb0295","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1046\/j.1523-1755.2000.07509.x","article-title":"The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease","volume":"57","author":"Klahr","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2021.120185_bb0300","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ndt\/16.suppl_1.34","article-title":"Up-regulation of endoglin, a TGF-\u03b2-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction","volume":"16","author":"Rodr\u00edguez-Pe\u00f1a","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2021.120185_bb0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1471-4892(02)00144-3","article-title":"Therapeutic strategies to halt renal fibrosis","volume":"2","author":"Yu","year":"2002","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120185_bb0310","series-title":"New Insights Into Epithelial-Mesenchymal Transition in Kidney Fibrosis","first-page":"212","volume":"vol. 21","author":"Liu","year":"2010"},{"key":"10.1016\/j.lfs.2021.120185_bb0315","series-title":"Adjuvant Strategies for Prevention of Glomerulosclerosis","first-page":"1277","volume":"vol. 67","author":"McCarty","year":"2006"},{"key":"10.1016\/j.lfs.2021.120185_bb0320","first-page":"61","article-title":"Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives","volume":"128","author":"L\u00f3pez-Novoa","year":"2010","journal-title":"Therapeutics"},{"key":"10.1016\/j.lfs.2021.120185_bb0325","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1006809604193","article-title":"Ehrlich ascites tumor cells produce a transforming growth factor-\u03b2 (TGF\u03b2)-like activity but lack receptors with TGF\u03b2-binding capacity","volume":"170","author":"Elexpuru","year":"1997","journal-title":"Biochemistry C"},{"key":"10.1016\/j.lfs.2021.120185_bb0330","series-title":"The Basics of Epithelial-Mesenchymal Transition","first-page":"1786","volume":"vol. 120","author":"Kalluri","year":"2010"},{"key":"10.1016\/j.lfs.2021.120185_bb0335","series-title":"Diverse Roles of TGF-\u03b2\/Smads in Renal Fibrosis and Inflammation","first-page":"1056","volume":"vol. 7","author":"Lan","year":"2011"},{"key":"10.1016\/j.lfs.2021.120185_bb0340","series-title":"Smad-dependent and Smad-independent Pathways in TGF-\u03b2 Family Signalling","first-page":"577","volume":"vol.425","author":"Derynck","year":"2003"},{"key":"10.1016\/j.lfs.2021.120185_bb0345","series-title":"Inhibition of Renal Fibrosis by Gene Transfer of Inducible Smad7 Using Ultrasound-Microbubble System in Rat UUO Model","first-page":"1535","volume":"vol. 14","author":"Lan","year":"2003"},{"key":"10.1016\/j.lfs.2021.120185_bb0350","series-title":"Disruption of Smad4 Impairs TGF-\u03b2\/Smad3 and Smad7 Transcriptional Regulation During Renal Inflammation and Fibrosis In vivo and In vitro","first-page":"266","volume":"vol. 81","author":"Meng","year":"2012"},{"key":"10.1016\/j.lfs.2021.120185_bb0355","series-title":"Ameliorating Effect of Gemigliptin on Renal Injury in Murine Adriamycin-induced Nephropathy","first-page":"2017","author":"Kim","year":"2017"},{"key":"10.1016\/j.lfs.2021.120185_bb0360","series-title":"TGF-\u03b2: The Master Regulator of Fibrosis","first-page":"325","volume":"vol. 12","author":"Meng","year":"2016"},{"key":"10.1016\/j.lfs.2021.120185_bb0365","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/cvr\/cvs134","article-title":"Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress","volume":"95","author":"Gratia","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2021.120185_bb0370","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2021.120185_bb0375","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bbrc.2007.01.012","article-title":"Pirfenidone inhibits TGF-\u03b2 expression in malignant glioma cells","volume":"354","author":"Burghardt","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2021.120185_bb0380","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1517\/13543780903501539","article-title":"Pirfenidone: an anti-fibrotic therapy for progressive kidney disease","volume":"19","author":"Cho","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.lfs.2021.120185_bb0385","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bmcl.2013.11.038","article-title":"Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents","volume":"24","author":"Ma","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2021.120185_bb0390","series-title":"Pirfenidone Suppresses MAPK Signalling Pathway to Reverse Epithelial-Mesenchymal Transition and Renal Fibrosis","first-page":"589","volume":"vol. 22","author":"Li","year":"2017"},{"key":"10.1016\/j.lfs.2021.120185_bb0395","series-title":"Paricalcitol Attenuates Cyclosporine-induced Kidney Injury in Rats","first-page":"1076","volume":"vol. 77","author":"Park","year":"2010"},{"key":"10.1016\/j.lfs.2021.120185_bb0400","series-title":"Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy","first-page":"3382","volume":"17","author":"Tan","year":"2006"},{"key":"10.1016\/j.lfs.2021.120185_bb0405","series-title":"A Nonclassical Vitamin D Receptor Pathway Suppresses Renal Fibrosis","first-page":"4579","volume":"vol. 123","author":"Ito","year":"2013"},{"key":"10.1016\/j.lfs.2021.120185_bb0410","series-title":"Vitamin D Inhibition of Pro-fibrotic Effects of Transforming Growth Factor \u03b21 in Lung Fibroblasts and Epithelial Cells","first-page":"142","volume":"vol. 118","author":"Ramirez","year":"2010"},{"key":"10.1016\/j.lfs.2021.120185_bb0415","series-title":"Effect of 1,25 (OH) 2 Vitamin D3 on Glomerulosclerosis in Subtotally Nephrectomized Rats","first-page":"1696","volume":"vol. 53","author":"Schwarz","year":"1998"},{"key":"10.1016\/j.lfs.2021.120185_bb0420","series-title":"Computational Approaches for Drug Discovery","author":"Brogi","year":"2019"},{"key":"10.1016\/j.lfs.2021.120185_bb0425","doi-asserted-by":"crossref","first-page":"10027","DOI":"10.1039\/D0RA10674G","article-title":"Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study","volume":"11","author":"Elmaaty","year":"2021","journal-title":"RSC Adv."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521011723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521011723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T10:33:21Z","timestamp":1717238001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521011723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":85,"alternative-id":["S0024320521011723"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120185","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pirfenidone and vitamin D mitigate renal fibrosis induced by doxorubicin in mice with Ehrlich solid tumor","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120185"}}